Niagen Bioscience to Present at Canaccord Genuity’s 46th Annual Growth Conference

Niagen Bioscience to Present at Canaccord Genuity’s 46th Annual Growth Conference

Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced that its Chief Executive Officer, Rob Fried, and Chief Financial Officer, Ozan Pamir, will participate in Canaccord Genuity’s 46th Annual Growth Conference, taking place from August 11 to 13, 2026, in Boston.